AIM aimimmuno.com Earnings per share growth this year
The reliability of AIM ImmunoTech (AIM) is based on attracting elite virologists through generous stock option programs. Annual earnings per share growth confirms this stability, with the value recorded at 90.10. While the team is motivated by the fight against pandemics, delays in bringing Ampligen to market are gradually eroding competitive advantages and overall business margins.
Analytical breakdowns and data insights for company AIM ImmunoTech (AIM)
- market value and analyst target forecast:
- market capitalization data:
- book capitalization information:
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient AIM ImmunoTech|AIM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio aimimmuno.com|AIM - Company Total Debt|Debt to Net Assets Ratio AIM ImmunoTech Inc.|AIM - Company Long-Term Debts|Short-Term Debt Volume AIM ImmunoTech|Quick Liquidity Indicator aimimmuno.com
- company profitability and valuation multiples indicators:
AIM - Company Net Income|Future Profit AIM ImmunoTech|AIM - Price to Earnings Ratio|Forward P/E Multiple AIM ImmunoTech, Inc.|AIM - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation AIM ImmunoTech Inc.|AIM - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months AIM ImmunoTech|AIM - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months aimimmuno.com|AIM - Earnings growth in current year|Expected net earnings per share growth next year AIM ImmunoTech
Summary company analysis:AIM ImmunoTech, Inc. (AIM)
To assess the fundamental stability of AIM ImmunoTech (AIM), it is critical for investors to track capital efficiency dynamics. This indicator measures the rate of change in earnings per share compared to the same period last year, identifying trends in profitability or deepening losses. An analysis of the relative change in EPS year-over-year confirms a cash burn stage dedicated to clinical trials in the absence of a stable cash flow.
Direct competitors
argenx N.V. (ARGX) - Earnings growth in current year|Earnings per share growth in current year BioNTech Group|Earnings per share growth this year ABVX (abivax.com)|Earnings growth in current year ADMA|PTGX - Earnings per share growth rate in current year|Earnings growth in current year IMVT (Immunovant)|Earnings growth in current year Kiniksa Pharmaceuticals, Ltd. KNSA|Grifols Group - Earnings growth in current year|Expected net earnings per share growth this year Adaptive Biotechnologies Inc. ADPT|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Net earnings per share growth this year auriniapharma.com|Net earnings per share growth this year BCRX|VERA: Earnings per share increase in current year|Earnings growth in current year DNTH|Expected net earnings per share growth this year Pharvaris Pharma|Earnings per share growth in current year AbCellera Biologics ABCL|TRML - Net earnings per share growth this year|PGEN - Earnings per share growth in current year|Pharming Group NV (PHAR) - Net earnings per share growth this year|NKTR (Nektar) - Net earnings per share growth this year|Upstream Pharma (UPB) - Earnings growth in current year|Earnings per share growth in current year Zenas Biopharma Inc|Earnings per share growth this year IMNM (immunome.com)|Earnings per share growth in current year Gossamer Bio (GOSS)|KALV - Earnings per share growth rate in current year|Septerna Corp - Net earnings per share growth this year|Net earnings per one share growth for the current year PVLA (Pieris Corp)|Savara Inc. - Earnings growth in current year|Earnings per share growth rate in current year rigel.com|ANAB: Earnings growth in current year|Net earnings per share growth this year Astria Therapeutics Inc|ENGN (enGene Bio) - Earnings growth in current year|RAPT: Earnings per share increase in current year|Earnings growth in current year JBIO|Earnings growth in current year aclaristx.com (ACRS)|Earnings growth in current year KYTX (Kyverna Therapeutics, Inc.)|Expected net earnings per share growth this year Tiziana Life Sciences Ltd. (TLSA)|CABA - Earnings per share growth in current year|Ventyx Biosciences, Inc (VTYX) - Net earnings per share growth this year|Theratechnologies Inc. (THTX) - Earnings per share growth in current year|Earnings per share trend in current year AVTX (avalotx.com)|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|AGEN: Earnings per share increase in current year|Earnings growth in current year CLYM|Earnings growth in current year Zura Bio Ltd (ZURA)|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|Earnings per share increase in current year ADAG|IMA - Earnings per share growth in current year|Shattuck Labs, Inc. (STTK) - Net earnings per share growth this year|EQ: Earnings growth in current year|Connect Biopharma Holdings Limited (CNTB) - Earnings growth in current year|Net earnings per share growth this year IMUX|ATRA: Earnings per share increase in current year|Earnings growth in current year IFRX|Expected net earnings per share growth this year X4 Pharmaceuticals Inc.|Earnings per share growth in current year Adicet Bio, Inc. ACET|CELU - Net earnings per share growth this year|INMB - Earnings per share growth in current year|barinthusbio.com (BRNS) - Net earnings per share growth this year|KZR (Kezar Life Sciences, Inc.) - Net earnings per share growth this year|SAB Biotherapeutics Inc. (SABS) - Earnings growth in current year|Earnings per share growth in current year Akari Therapeutics plc|Earnings per share growth this year ENLV (Enlivex Therapeutics, Ltd.)|Earnings growth in current year QTTB|GOVX - Earnings per share growth rate in current year|Earnings growth in current year EDSA (Edesa Biotech)|Earnings growth in current year iBio Inc IBIO|Carisma Tx - Earnings growth in current year|Expected net earnings per share growth this year XTL Bio XTLB|boltbio.com (BOLT) - Earnings per share growth in current year|Net earnings per share growth this year HCW Biologics|Net earnings per share growth this year APVO|ADTX: Earnings per share increase in current year|Earnings growth in current year GRI|Expected net earnings per share growth this year XORTX Corp|Earnings per share growth in current year Vyome Holdings Inc HIND|REVB - Net earnings per share growth this year|INDP - Earnings per share growth in current year|Scinai Immunotherapeutics Ltd (SCNI) - Net earnings per share growth this year|CALI (calcimedica.com) - Net earnings per share growth this year|Affimed N.V. (AFMD) - Earnings growth in current year|Earnings per share growth in current year Allakos Inc|Earnings per share growth this year HOOK (HOOKIPA)|Earnings per share growth in current year IGM Biosciences, Inc. (IGMS)|ITOS - Earnings per share growth rate in current year|Ocean Bio - Net earnings per share growth this year|Net earnings per one share growth for the current year TCBP (TC BioPharm Ltd)|Third Harmonic Bio - Earnings growth in current year
